An Open Label Trial to Decrease Signs and Symptoms of Orthostatic Hypotension Using Midodrine in Patients With Preserved Cardiac Output (CO) and an Intravenous Fluid Bolus for Patients With Low CO Following Total Hip Arthroplasty
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Midodrine (Primary)
- Indications Orthostatic hypotension
- Focus Therapeutic Use
Most Recent Events
- 20 Jan 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 11 Jul 2014 New trial record